International Clinical Trial: Efficacy and Safety of Ivarmacitinib in the Treatment of Moderate-to-Severe Oral Lichen Planus

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127194) titled 'Efficacy and Safety of Ivarmacitinib in the Treatment of Moderate-to-Severe Oral Lichen Planus' on June 26.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Air Force Medical University

Condition: Oral lichen planus

Intervention: Ivarmacitinib treatment group:1. Weeks 0-8 after enrollment: Ivarmacitinib Sulfate Tablets, 4 mg/day orally + Triamcinolone Acetonide Oral Ointment, applied topically to lesions twice daily 2. Weeks 9-16 after enrollment: Ivarmacitinib Sulfate Tablets, 4 mg/day orally + Triamcinolone Acetonide Oral Ointment, applied topically...